These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21091965)

  • 1. Defibrillation thresholds in hypertrophic cardiomyopathy.
    Quin EM; Cuoco FA; Forcina MS; Coker JB; Yoe RH; Spencer WH; Fernandes VL; Nielsen CD; Sturdivant JL; Leman RB; Wharton JM; Gold MR
    J Cardiovasc Electrophysiol; 2011 May; 22(5):569-72. PubMed ID: 21091965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defibrillation threshold testing in patients with hypertrophic cardiomyopathy.
    Roberts BD; Hood RE; Saba MM; Dickfeld TM; Saliaris AP; Shorofsky SR
    Pacing Clin Electrophysiol; 2010 Nov; 33(11):1342-6. PubMed ID: 20663074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of defibrillation efficacy using implantable cardioverter-defibrillator with single- or dual-coil defibrillation leads and active can.
    Lubiński A; Lewicka-Nowak E; Zienciuk A; Królak T; Kempa M; Pazdyga A; Raczak G; Swiatecka G
    Kardiol Pol; 2005 Sep; 63(3):234-41; discussion 242-3. PubMed ID: 16180177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of defibrillation testing on management during implantable cardioverter-defibrillator implantation.
    Leong-Sit P; Gula LJ; Diamantouros P; Krahn AD; Skanes AC; Yee R; Klein GJ
    Am Heart J; 2006 Dec; 152(6):1104-8. PubMed ID: 17161062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of shock polarity reversal on defibrillation threshold in an implantable cardioverter-defibrillator.
    Zienciuk A; Lubiński A; Królak T; Lewicka-Nowak E; Kempa M; Pazdyga A; Raczak G
    Kardiol Pol; 2007 May; 65(5):495-500; discussion 501-2. PubMed ID: 17577846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Massive myocardial hypertrophy in hypertrophic cardiomyopathy: a risk factor for sudden death and high defibrillation threshold during cardioverter-defibrillator implantation].
    Jastrzebski M; Czarnecka D; Bacior B; Petkow-Dimitrow P; Wilczek R; Kawecka-Jaszcz K
    Kardiol Pol; 2005 Aug; 63(2):191-5; discussion 196. PubMed ID: 16136416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of an active abdominal pulse generator on defibrillation thresholds with a dual-coil, transvenous ICD lead system.
    Rashba EJ; Farasat M; Kirk MM; Shorofsky SR; Peters RW; Gold MR
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):617-20. PubMed ID: 16836709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QRS prolongation is associated with high defibrillation thresholds during cardioverter-defibrillator implantations in patients with hypertrophic cardiomyopathy.
    Nagai T; Kurita T; Satomi K; Noda T; Okamura H; Shimizu W; Suyama K; Aihara N; Kobayashi J; Kamakura S
    Circ J; 2009 Jun; 73(6):1028-32. PubMed ID: 19359812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Implications of Defibrillation Threshold Testing in Patients With Hypertrophic Cardiomyopathy.
    Francia P; Adduci C; Semprini L; Palano F; Santini D; Musumeci B; Santolamazza C; Volpe M; Autore C
    J Cardiovasc Electrophysiol; 2017 Jan; 28(1):103-108. PubMed ID: 27862589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Tuned" defibrillation waveforms outperform 50/50% tilt defibrillation waveforms: a randomized multi-center study.
    Natarajan S; Henthorn R; Burroughs J; Esberg D; Zweibel S; Ross T; Kroll M; Gianola D; Oza A
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S139-42. PubMed ID: 17302691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of atrial defibrillation with a dual-coil, active pectoral lead system.
    Rashba EJ; Shorofsky SR; Peters RW; Gold MR
    J Cardiovasc Electrophysiol; 2004 Jul; 15(7):790-4. PubMed ID: 15250864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary prevention implantation of cardioverter defibrillator without defibrillation threshold testing: 2-year follow-up.
    Bianchi S; Ricci RP; Biscione F; Sgreccia F; Di Belardino N; Rossi P; Giuli S; Grammatico A; De Santo T; Santi E; Merico M; Piccirillo G; Azzolini P; Santini M; Puglisi A
    Pacing Clin Electrophysiol; 2009 May; 32(5):573-8. PubMed ID: 19422577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of high defibrillation threshold in the modern era.
    Lin EF; Dalal D; Cheng A; Marine JE; Nazarian S; Sinha S; Spragg DD; Tandri H; Halperin H; Calkins H; Berger RD; Tomaselli GF; Henrikson CA
    Pacing Clin Electrophysiol; 2013 Feb; 36(2):231-7. PubMed ID: 23121046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achieving sufficient safety margins with fixed duration waveforms and the use of multiple time constants.
    Keane D; Aweh N; Hynes B; Sheahan RG; Cripps T; Bashir Y; Zaidi A; Fahy G; Lowe M; Doherty P; Kroll MK
    Pacing Clin Electrophysiol; 2007 May; 30(5):596-602. PubMed ID: 17461867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical predictors of defibrillation threshold in patients with implantable cardioverter-defibrillators.
    Lubiński A; Lewicka-Nowak E; Zienciuk A; Królak T; Kempa M; Pazdyga A; Swiatecka G
    Kardiol Pol; 2005 Apr; 62(4):317-28; discussion 329-31. PubMed ID: 15928737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative defibrillation threshold testing during implantable cardioverter-defibrillator insertion: do we really need it?
    Calvi V; Dugo D; Capodanno D; Arancio R; Di Grazia A; Liotta C; Puzzangara E; Ragusa A; Arestia A; Tamburino C
    Am Heart J; 2010 Jan; 159(1):98-102. PubMed ID: 20102873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High defibrillation threshold in patients with implantable defibrillator: how effective is the subcutaneous finger lead?
    Osswald BR; De Simone R; Most S; Tochtermann U; Tanzeem A; Karck M
    Eur J Cardiothorac Surg; 2009 Mar; 35(3):489-92. PubMed ID: 19144533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-coil vs single-coil active pectoral implantable defibrillator lead systems: defibrillation energy requirements and probability of defibrillation success at multiples of the defibrillation energy requirements.
    Schulte B; Sperzel J; Carlsson J; Schwarz T; Ehrlich W; Pitschner HF; Neuzner J
    Europace; 2001 Jul; 3(3):177-80. PubMed ID: 11467457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of defibrillation thresholds using monodirectional electrical vector versus bidirectional electrical vector.
    Libero L; Lozano IF; Bocchiardo M; Marcolongo M; Sallusti L; Madrid A; Gaita F; Trevi GP
    Ital Heart J; 2001 Jun; 2(6):449-55. PubMed ID: 11453582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.